SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

$WAGMI is trending as the community rallies around its potential, emphasizing a conviction-based approach over hype. Talk centers on the token's strong community and resilience within the $SOL ecosystem, with many expressing a shared belief that 'we're all gonna make it.'

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending due to a mixed reaction to earnings, with initial positive revenue overshadowed by a one-time tax charge and concerns about increased spending on AI infrastructure. The community is debating whether the dip is a buying opportunity or a sign of deeper issues with the company's investment strategy. Some investors believe the market is overreacting, while others are wary of Meta's increasing capital expenditures.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending with community members actively discussing potential integrations with Solana ($SOL) and USDC. Some users express bullish sentiment, while others are cautioning about potential risks. The conversation includes community-specific language such as WAGMI (We Are All Going to Make It).

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors analyze the implications of the company's recent earnings report, particularly regarding its AI spending and Azure cloud growth. Community discussions revolve around whether the earnings justify the current valuation and forward guidance. The broader context includes Microsoft's significant stake in OpenAI and its ongoing competition in the cloud computing arena against companies like Amazon and Google.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid anticipation for an upcoming meeting between President Trump and China's President Xi, with trade deal hopes influencing market sentiment. Community members are actively discussing potential impacts on major tech companies following mixed earnings reports from key players like Microsoft and Meta, while some express concern about an over-reliance on a few top stocks. Investors are weighing the potential for further market gains against concerns about stretched valuations and the broader economic outlook.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVDA is trending as investors digest news around potential chip sales to China following discussions between Trump and Xi, with community sentiment fluctuating based on the perceived outcomes of these talks. Discussions also revolve around Nvidia's high valuation and potential impact of increased capital expenditure from major tech companies. The stock's performance is closely tied to broader AI sector trends and regulatory developments.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle's stock is trending due to a significant post-earnings drop, sparking discussions about reduced guidance and declining customer traffic amid macroeconomic pressures. Community members are debating the company's valuation, food quality, portion sizes, and pricing, with some suggesting it's oversold and ripe for institutional investment while others point to waning popularity. The impact of tariffs and competition from other fast-casual restaurants like CAVA are also being considered.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending as the stock flirts with all-time highs, sparking discussions about a potential stock split and future growth prospects. The community is weighing the impact of recent partnerships, particularly with Nvidia, and anticipating upcoming earnings. Despite valuation concerns, bullish sentiment prevails, fueled by the company's perceived leadership in AI and strong retail investor base.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending due to a significant stock drop following disappointing earnings and a lowered outlook, prompting analysts to downgrade the stock. The community is discussing potential corporate fraud, a management shakeup, and whether this presents a buying opportunity or a value trap. Some are hopeful for a quick bounce, while others are wary of deeper declines and possible investigations.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

EBS is trending as traders discuss a potential short squeeze and the stock's undervaluation following recent earnings and future growth prospects. Community members are focused on potential price targets and the possibility of a buyout, while also analyzing short interest and options activity. Speculation about analyst upgrades and the impact of potential government actions are contributing to the heightened interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Guardant Health’s Q3 revenue surged 39% year-over-year to $265.2 million, led by strong growth in its oncology, screening, and biopharma segments.</li><li>The company raised its 2025 revenue guidance to as much as $970 million, projecting 31% annual growth and highlighting momentum in its Shield cancer screening test.</li><li>Retail traders on Stocktwits turned “extremely bullish” after the results, calling the stock a long-term winner as Guardant moves closer to cash-flow positivity.</li></ul>Shares of Guardant Health jumped 21% in after-hours trading on Wednesday after the oncology company posted a 39% year-over-year revenue growth and raised its 2025 guidance.Revenue for the third quarter rose to $265.2 million, led by strong performance across its oncology, screening, biopharma, and data segments. Oncology revenue climbed 31% to $184.4 million on a 40% increase in test volume, while screening revenue surged to $24.1 million from just $1 million a year earlier, driven by growing adoption of its Shield test. Biopharma and data revenue rose 18% to $54.7 million.The company reported a non-GAAP gross margin of 66%, up from 63% in the same period last year.<h2 class="st-heading-2">Outlook</h2>Guardant lifted its 2025 full-year revenue forecast to a range of $965 million to $970 million, up 31% year-over-year, compared to its prior outlook of $915 million to $925 million.The company expects oncology revenue to grow about 25% in 2025, with volume expansion exceeding 30%, while screening revenue is projected between $71 million and $73 million on 80,000 to 82,000 Shield tests.Guardant closed the quarter with $689.5 million in cash and equivalents, reporting a net loss of $92.7 million, narrower than the $107.8 million loss a year earlier.<h2 class="st-heading-2">Growth Drivers</h2>Guardant said the quarter marked “broad-based growth” across its business. The company expanded Shield to multi-cancer detection, launched a large-scale real-world data initiative, and formed strategic partnerships with Quest Diagnostics and PathGroup to broaden access.It also submitted its Guardant360 Liquid PMA application to the FDA and submitted Reveal immuno-oncology monitoring data to MolDx for Medicare reimbursement. Additionally, new companion diagnostic approvals were granted for breast cancer and non-small cell lung cancer.Co-CEO Helmy Eltoukhy said Guardant crossed $1 billion in annualized revenue, calling it a milestone that “sets us up well to deliver on the long-term plan presented at our Investor Day last month.”<h2 class="st-heading-2">Guardant’s Q3 Print Ignites Retail Optimism On Stocktwits</h2>On Stocktwits, retail sentiment for Guardant was ‘extremely bullish’ amid a 1,100% surge in 24-hour message volume.One user said the company’s latest earnings call convinced them to boost their stake, noting that revenues appeared to be at an inflection point and could accelerate meaningfully in 2026 as the platform’s strength becomes clearer.&nbsp;They added that Guardant has the potential to become one of the largest and most profitable testing firms as its technology matures, and welcomed news that it is on track to turn cash-flow positive ahead of schedule.<stembedurl>https://stocktwits.com/WantedToRetireEarly/message/634232116</stembedurl>Another user viewed Guardant Health as a strong long-term holding.<stembedurl>https://stocktwits.com/Boring_Kitty/message/634219795</stembedurl><a href="https://stocktwits.com/symbol/GH">Guardant’s stock</a> has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Guardant’s stock (GH) has more than doubled so far in 2025. (Photo credit: Getty Images)

Guardant Health Stock Soars 21% After-Hours As Strong Q3, Raised Guidance Spark Retail Frenzy

Guardant Health’s Q3 revenue surged 39% year-over-year to $265.2 million, led by strong growth in its oncology, screening, and biopharma segments.

Equity

Guardant Health (GH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Guardant Health (GH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Guardant Health (GH) Reports Q3 Loss, Beats Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of +18.75% and +13.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights For the...

Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals

TEM secures multiple FDA clearances in 2025, boosting its AI-driven diagnostic portfolio across oncology and cardiology.

Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights

Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence to accelerate drug development, today announced a...

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data showing the critical role of blood-based testing...

Tempus AI Fuels Growth Through Strategic Biotech Collaborations

TEM expands its AI-driven growth with new collaborations in oncology, neurogenomics, and diagnostic innovation.

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that new data from across its oncology portfolio will be presented in 15 accepted abstracts at the European...

Guardant Health to Report Third Quarter 2025 Financial Results on October 29, 2025

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2025 after market close on Wednesday, October 29...

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Guardant Health Inc

Will Apple (AAPL) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.78	--	--	N/A
Q3 '25	-$0.79	-$0.74	6.28%	BEAT
Q2 '25	-$0.72	-$0.80	-11.72%	MISSED
Q1 '25	-$0.76	-$0.77	-1.27%	MISSED
Q4 '24	-$0.75	-$0.90	-19.83%	MISSED

GH
Guardant Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest GH News

GHGuardant Health Inc